| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |